Pharmacological treatment of depression

EBM Guidelines
Jun 1, 2020 • Latest change Feb 5, 2024
Heikki Rytsälä

Table of contents

Extract

  • Choose the correct antidepressant.
  • Ensure the dose is large enough to produce a beneficial effect.
  • Treatment should be of sufficient duration.
  • Medication should support other treatments (psychotherapeutic support).
  • Prophylaxis is necessary in recurrent depression.

Read full article of Pharmacological treatment of depression

Linked evidence summaries

Search terms

Aged, Agomelatin, Agranulocytosis, Amitriptyline, Anti-Anxiety Agents, Antidepressive Agents, Antidepressive Agents, Tricyclic, Anxiety, Bulimia, Bulimia Nervosa, Citalopram, Clomipramine, Depression, Doxepin, Dysthymic Disorder, Epilepsy, F32, F33, F34.1, Fluoxetine, Fluvoxamine, Hepatic Insufficiency, Hypericum, Imipramine, Kidney Failure, Lithium, MAO A inhibitors, Mianserin, Moclobemide, Monoamine Oxidase Inhibitors, Neutropenia, Nortriptyline, Paroxetine, Psychiatry, Psychotropic Drugs, Renal Insufficiency, SNRI, SSRI, Serotonin Uptake Inhibitors, Sertraline, Sleep Initiation and Maintenance Disorders, St John's wort, Sulpiride, Trazodone, Trimipramine, Warfarin, benzodiazepines, depression, psychotic, escitalopram, selective serotonin and noradrenalin uptake inhibitors, tardive dyskinesia, tetracyclic antidepressants, venlafaxine